Vijaya Diagnostic Centre

Vijaya Diagnostic Centre

999.90
+0.30
(0.03%)
ann
There are new updates from the company1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
Market Cap
10,268.40 Cr
EPS
13.95
PE Ratio
68.04
Dividend Yield
0.20 %
52 Week High
1,275.00
52 Week Low
740.00
PB Ratio
12.90
Debt to Equity
0.40
Analyst Rating and Forecast
- By Refinitiv from7 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+42.86 %
+42.86 %
Hold
Hold+28.57 %
+28.57 %
Sell
Sell+28.57 %
+28.57 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Vijaya Diagnostic Centre Limited announced that Mr. Srinivas Lanka, Chief Technology Officer, has resigned due to personal reasons with his last working day being November 15, 2025. Separately, the company received the certified true copy of the NCLT order dated October 13, 2025, approving the scheme of amalgamation with Medinova Diagnostic Services Limited. The merger will become effective when the order is filed with the Registrar of Companies in Hyderabad. The record date for share allotment to Medinova shareholders will be announced later.
positive
The National Company Law Tribunal, Hyderabad Bench has approved the Scheme of Amalgamation between Medinova Diagnostic Services Limited and Vijaya Diagnostic Centre Limited. The final order was pronounced on October 13, 2025, with an appointed date of April 1, 2024. Under the scheme, shareholders of Medinova will receive 1 equity share of Vijaya for every 22 shares held. Vijaya Diagnostic Centre, which holds 62.14% stake in Medinova, will see its shares in the transferor company cancelled. The amalgamation aims to consolidate business operations, create synergies, reduce costs, and improve operational efficiency in the diagnostic services sector. Both companies are listed entities engaged in providing comprehensive diagnostic services including pathological investigations, radiology, and nuclear medicine. The scheme becomes effective upon filing with the Registrar of Companies.
neutral
V. Siva Rama Raju Vegesna, Operations Vice President at Vijaya Diagnostic Centre, has resigned for personal reasons with effect from November 8, 2025. The company acknowledged his six-year service period with the organization.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
3,091.70
#1 26,339.90
50.77
#1 2,554.80
11.28
#1 492
24.30
44.84
999.90
#2 10,268.40
#9 68.04
#6 699.70
#3 23.06
#3 144
#4 22.54
46.94
1,944.10
10,119.00
66.27
1,346.30
10.64
146
18.90
42.43
1,330.30
6,834.70
54.00
702.20
20.80
91
81.06
64.57
795.65
2,575.30
32.11
742.70
16.70
78
14.53
45.66
322.85
1,690.00
52.05
255.90
15.11
31
19.48
66.85
1,325.05
1,134.30
23.13
111.60
28.72
48
11.50
35.58
299.90
966.10
#1 -6.46
1,170.80
-18.47
-134
-35.12
44.49
349.70
669.50
25.21
147.80
#1 134.60
19
#1 444.44
66.60
145.55
109.50
73.46
41.80
13.28
2
0.00
25.38
Growth Rate
Revenue Growth
23.06 %
Net Income Growth
20.23 %
Cash Flow Change
22.46 %
ROE
-0.77 %
ROCE
-1.44 %
EBITDA Margin (Avg.)
-1.98 %

Quarterly Financial Results

Quarterly Financials
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
54
116
103
116
126
116
114
119
107
124
117
126
127
146
138
159
160
188
174
179
195
Expenses
38
62
54
58
66
62
63
68
65
72
69
72
73
82
82
92
95
107
102
105
115
EBITDA
16
54
49
59
60
54
51
51
43
52
48
54
54
64
55
66
65
81
72
73
81
Operating Profit %
27 %
45 %
46 %
49 %
46 %
45 %
43 %
41 %
38 %
40 %
39 %
41 %
40 %
41 %
38 %
41 %
39 %
42 %
40 %
39 %
39 %
Depreciation
12
14
13
13
12
13
13
15
14
16
20
11
13
14
15
16
17
17
18
19
21
Interest
4
4
4
4
4
4
4
4
5
5
6
6
6
6
6
6
6
7
7
7
8
Profit Before Tax
1
36
33
43
44
38
34
31
24
31
22
37
36
45
35
44
42
57
47
47
52
Tax
-1
9
8
11
11
10
8
8
6
8
6
9
9
11
9
10
10
15
11
13
14
Net Profit
2
27
25
32
33
28
26
24
18
24
17
28
26
34
26
34
32
42
35
35
39
EPS in ₹
3.55
2.59
2.43
3.08
3.23
2.72
2.48
2.33
1.71
2.29
1.60
2.69
2.57
3.26
2.53
3.27
3.06
4.09
3.42
3.38
3.76

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
234
301
482
541
714
853
983
1,274
Fixed Assets
119
151
272
268
371
524
742
865
Current Assets
103
138
186
239
270
276
211
307
Capital Work in Progress
3
3
10
9
34
28
9
70
Investments
73
69
55
28
54
139
109
185
Other Assets
39
78
146
236
255
163
123
154
Total Liabilities
234
301
482
541
714
853
983
1,274
Current Liabilities
40
50
59
44
66
66
73
163
Non Current Liabilities
33
40
150
138
178
241
250
312
Total Equity
161
211
274
359
470
547
660
799
Reserve & Surplus
155
204
270
355
458
535
647
786
Share Capital
5
5
5
5
10
10
10
10

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-44
-7
46
-49
4
13
-2
-9
Investing Activities
-98
-90
-31
-130
-123
-110
-141
-182
Operating Activities
62
91
106
130
158
165
183
225
Financing Activities
-8
-7
-30
-49
-31
-42
-45
-52

Share Holding

% Holding
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
60.00 %
54.78 %
54.78 %
54.78 %
55.04 %
55.01 %
55.01 %
55.01 %
54.98 %
54.90 %
54.87 %
54.06 %
53.93 %
53.91 %
53.91 %
53.05 %
52.63 %
52.60 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
20.09 %
20.08 %
18.14 %
17.54 %
19.36 %
19.56 %
18.27 %
DIIs
0.00 %
14.09 %
13.30 %
12.88 %
12.76 %
15.28 %
14.23 %
13.90 %
19.03 %
17.99 %
19.55 %
20.80 %
21.49 %
23.46 %
24.63 %
23.72 %
24.07 %
25.34 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
5.45 %
3.71 %
3.82 %
4.00 %
4.97 %
5.18 %
5.13 %
5.03 %
5.06 %
4.63 %
4.38 %
3.98 %
3.94 %
3.43 %
3.42 %
3.24 %
3.20 %
Others
40.00 %
25.68 %
28.21 %
28.52 %
28.20 %
24.74 %
25.58 %
25.96 %
20.96 %
22.05 %
20.95 %
0.67 %
0.52 %
0.55 %
0.49 %
0.45 %
0.50 %
0.59 %
No of Share Holders
7
2,34,724
82,139
79,021
77,229
76,985
79,059
76,532
73,850
72,795
66,204
66,724
62,415
62,258
60,952
66,891
62,115
58,994

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 1 1 1 2
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.25 0.16 0.1 0.2

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
21 Sept 2022 DIVIDEND Dividend
₹ 1.00 /share
20 Sept 2022 389.20 402.80
13 Sept 2023 DIVIDEND Dividend
₹ 1.00 /share
13 Sept 2023 376.05 473.60
30 Aug 2024 DIVIDEND Dividend
₹ 1.00 /share
30 Aug 2024 666.50 892.05
06 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
06 Sept 2024 819.35 948.50
07 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2024 933.90 980.25
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 1,159.65 1,076.90
25 Apr 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
25 Apr 2025 1,050.75 1,061.30
12 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 May 2025 1,017.75 993.85
28 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jul 2025 1,045.40 1,070.30
29 Aug 2025 DIVIDEND Dividend
₹ 2.00 /share
29 Aug 2025 993.85 993.45
05 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 Sept 2025 1,049.85 1,088.45

Announcements

Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Is Scheduled On 04/11/2025 Inter Alia To Consider And Approve The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Second Quarter And Half Year E1 day ago
Announcement under Regulation 30 (LODR)-Change in Management9 days ago
Announcement under Regulation 30 (LODR)-Scheme of Arrangement9 days ago
Announcement under Regulation 30 (LODR)-Scheme of ArrangementOct 16, 2025
Shareholders Communication Relating To Saksham Niveshak CampaignOct 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 03, 2025
Resignation Of Vice President - Operations (Mr. V. Siva Rama Raju Vegesna)Oct 01, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementSep 29, 2025
Closure of Trading WindowSep 25, 2025
Rumour verification - Regulation 30(11)Sep 20, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 19, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 06, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Weblink Letter To Shareholders - As Per Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 13, 2025
Weblink Letter To Shareholders - As Per Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 13, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 13, 2025
Reg. 34 (1) Annual Report.Aug 13, 2025
Notice Of The 23Rd Annual General Meeting (AGM) Of Vijaya Diagnostic Centre LimitedAug 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2025
Corporate Action - Record Date Friday 29Th August 2025 Fixed For Dividend PaymentAug 12, 2025
Information Relating To 23Rd Annual General Meeting (AGM) Record Date And Cut-Off Date For E-Voting & AGM.Aug 12, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 04, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 28, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Jul 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 28, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 28, 2025
Appointment Of Secretarial AuditorJul 28, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 28, 2025
Board Meeting Outcome for Financial Results For The Quarter Ended June 30 2025Jul 28, 2025
Financial Result For The Quarter Ended June 30 2025Jul 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 18, 2025
Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30 2025.Jul 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 02, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 07, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 20, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 12, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 12, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 12, 2025
Corporate Action-Board approves DividendMay 12, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Tata India Pharma & Healthcare Fund Direct-Growth
1.55%
200823
1.55%
1.55%
Union Small Cap Fund Direct-Growth
1.23%
183970
1.07%
1.23%
Motilal Oswal Small Cap Fund Direct - Growth
2.41%
97597
0.08%
0.08%
ICICI Prudential Innovation Fund Direct - Growth
1.14%
93413
0.12%
0.05%
ITI Pharma and Healthcare Fund Direct - Growth
0.00%
-34264
-1.52%
-1.56%
Axis Aggressive Hybrid Fund Direct-Growth
0.19%
18449
0.12%
0.19%
Axis Balanced Advantage Fund Direct-Growth
0.53%
15942
0.03%
-0.02%
Axis Consumption Fund Direct-Growth
0.54%
-7826
-0.01%
-0.18%
Tata India Innovation Fund Direct-Growth
0.03%
5391
0.03%
0.03%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
-902
-0.01%
-0.02%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
850
-0.01%
0.25%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.20%
-839
-0.02%
-0.03%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
398
-0.01%
-0.02%
Kotak Small Cap Fund Direct-Growth
3.10%
387
-0.02%
-0.04%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.24%
-363
-0.01%
-0.02%
Kotak Pioneer Fund Direct - Growth
1.72%
356
-0.06%
0.51%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.25%
-302
-0.01%
-0.02%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.24%
-298
-0.02%
-0.03%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
-141
-0.01%
-0.02%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.06%
-125
0.00%
-0.01%
Motilal Oswal Nifty 500 Index Fund Direct - Growth
0.03%
116
0.00%
0.00%
Groww Nifty Smallcap 250 Index Fund Direct - Growth
0.24%
-107
-0.02%
-0.02%
SBI Nifty 500 Index Fund Direct-Growth
0.03%
-35
0.00%
0.00%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.24%
-20
-0.02%
-0.03%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.37%
-19
0.00%
-0.02%

Technical Indicators

RSI(14)
Neutral
46.80
ATR(14)
Less Volatile
25.55
STOCH(9,6)
Neutral
66.60
STOCH RSI(14)
Overbought
81.19
MACD(12,26)
Bullish
2.48
ADX(14)
Weak Trend
11.46
UO(9)
Bearish
50.48
ROC(12)
Uptrend And Accelerating
0.91
WillR(14)
Neutral
-43.37

About Vijaya Diagnostic Centre

Vijaya Diagnostic Centre Limited is an Indian company founded in 1981 and incorporated in 2002. It is the largest integrated diagnostic chain in South India, providing a comprehensive range of diagnostic services including pathological investigations, radiology, nuclear medicine, and related healthcare services. The company operates over 121 diagnostic centers across 20 cities in India, offering laboratory services, radiology and imaging, cardiology, neurology, and gastroenterology services. In 2021, Vijaya Diagnostic Centre Limited went public with an IPO of Rs 1895.04 crore and its shares were listed on the BSE and NSE.
Listing Date
14 Sept, 2021(4 Years, 14 days)
Chairperson NameSura Surendranath Reddy